Revvity, 6FC64PAG, HTRF CD64 Cellular Binding Kit, 100 Assay Points

Overview
The CD64 (FcgRI) cellular binding assay is a simple and robust test to monitor binding of the IgG Fc region to the human CD64 receptor in live cells and to select the most potent antibody for use in protective functions of the immune system. This assay, based on our innovative Tag-lite technology, can easily be automated to create a high-throughput solution for predicting phagocytosis and immune cell activation.
HTRF assays offer many advantages over other technologies:

Homogeneous add-and-read format
No wash steps
Low background
Straightforward miniaturization from 96- or 384-well microplates to high density assay formats such as 384-well low volume and 1536-well plates
Stable signal, providing flexibility in time of readout or size of assays
How it works
Assay principle
The CD64 receptor cellular binding assay is a competitive assay involving HEK293 cells expressing a specific CD64 variant conjugated to Lumi4-terbium Cryptate, and human IgG1 labelled with d2. The unlabeled antibody or Fc tagged drug competes with the d2 labelled IgG1 for binding to the receptor, resulting in a decrease of FRET signal.

Assay protocol
The CD64 receptor cellular binding assays (FcgI) present only 1 incubation step after reagents distribution. Lumi4-terbium Cryptate pre-labelled cells are dispensed, followed by the addition of IgG1 labelled with d2 and the sample. After 2h incubation at RT, the signal can be read. Application-Protein Quantification
Brand-HTRF
Detection Modality-HTRF
Product Group-Kit
Sample Volume-5 µL
Shipping Conditions-Shipped in Dry Ice
Target Class-Biologics
Technology-TR-FRET
Therapeutic Area-Cardiovascular Infectious Diseases Metabolism/Diabetes NASH/Fibrosis Neuroscience Rare Diseases
Unit Size-100 assay points